Microbiology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Microbiology 144 (1998), 333-341; DOI  10.1099/00221287-144-2-333
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Oyston, P. C. F.
Right arrow Articles by Titball, R. W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Oyston, P. C. F.
Right arrow Articles by Titball, R. W.
Agricola
Right arrow Articles by Oyston, P. C. F.
Right arrow Articles by Titball, R. W.

Production of a non-toxic site-directed mutant of Clostridium perfringens {varepsilon}-toxin which induces protective immunity in mice

Petra C. F. Oyston, Dean W. Payne, Helen L. Havard, E. Diane Williamson and Richard W. Titball

Defence Evaluation and Research Agency, CBD Porton Down, Salisbury, Wiltshire SP4 0JQ, UK

ABSTRACT

A panel of ten site-directed mutants of Clostridium perfringens {varepsilon}-toxin was generated. All of the mutated proteins expressed in Escherichia coli were recognized in immunoblots by a neutralizing mAb raised against wild-type native {varepsilon}-toxin. The cytotoxicity of the site-directed mutated toxins was assayed in vitro against MDCK cells. One mutation resulting in loss of activity in the assay was identified. This non-toxic protein was derived by substituting a proline for the histidine at residue 106 of the toxin. Immunization of mice with the non-toxic mutated {varepsilon}-toxin resulted in the induction of a specific antibody response and immunized mice were protected against 1000 LD50 doses of wild-type recombinant {varepsilon}-toxin.

Author for correspondence: Petra C. F. Oyston. Tel: +44 1980 613320. Fax: +44 1980 613284. e-mail: 100432.3200@compuserve.com


Keywords: Clostridium perfringens, vaccine, {varepsilon}-toxin, site-directed mutants




This article has been cited by other articles:


Home page
J. Biol. Chem.Home page
T. M. Pelish and M. S. McClain
Dominant-negative Inhibitors of the Clostridium perfringens {epsilon}-Toxin
J. Biol. Chem., October 23, 2009; 284(43): 29446 - 29453.
[Abstract] [Full Text] [PDF]


Home page
Infect. Immun.Home page
M. S. McClain and T. L. Cover
Functional Analysis of Neutralizing Antibodies against Clostridium perfringens Epsilon-Toxin
Infect. Immun., April 1, 2007; 75(4): 1785 - 1793.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
J. E. Purser and S. J. Norris
Correlation between plasmid content and infectivity in Borrelia burgdorferi
PNAS, December 5, 2000; 97(25): 13865 - 13870.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
INT J SYST EVOL MICROBIOL MICROBIOLOGY J GEN VIROL
J MED MICROBIOL ALL SGM JOURNALS
Copyright © 1998 Society for General Microbiology.